SARS-CoV-2 viral dynamics and population pharmacokinetics of favipiravir in combination with lopinavir-ritonavir in patients with COVID-19

被引：0
|
作者：
Agyeman, Akosua A. [1 ]
Brown, Li-An K. [2 ]
Guerra-Assuncao, Jose A.
Breuer, Judy [1 ,3 ]
Lowe, David M. [2 ,4 ]
Standing, Joseph F. [1 ,5 ]
机构：
[1] UCL, Great Ormond St Inst Child Hlth, Infect Immun & Inflammat Res & Teaching Dept, London, England
[2] UCL, Inst Immun & Transplantat, Royal Free Campus, London, England
[3] Great Ormond St Hosp Sick Children, Dept Microbiol, London, England
[4] Royal Free London NHS Fdn Trust, Dept Clin Immunol, London, England
[5] Great Ormond St Hosp Sick Children, Dept Pharm, London, England
来源：
BRITISH JOURNAL OF PHARMACOLOGY | 2023年 / 180卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
P0348
引用
收藏
页码：291 / 294
页数：4
相关论文
共 50 条
  • [41] Pharmacokinetics of Lopinavir and Ritonavir in Patients Hospitalized With Coronavirus Disease 2019 (COVID-19)
    Schoergenhofer, Christian
    Jilma, Bernd
    Stimpfl, Thomas
    Karolyi, Mario
    Zoufaly, Alexander
    ANNALS OF INTERNAL MEDICINE, 2020, 173 (08) : 670 - +
  • [42] SARS-CoV-2 viral load predicts COVID-19 mortality
    Pujadas, Elisabet
    Chaudhry, Fayzan
    McBride, Russell
    Richter, Felix
    Zhao, Shan
    Wajnberg, Ania
    Nadkarni, Girish
    Glicksberg, Benjamin S.
    Houldsworth, Jane
    Cordon-Cardo, Carlos
    LANCET RESPIRATORY MEDICINE, 2020, 8 (09): : E70 - E70
  • [43] Covid-19 convalescent plasma and SARS-CoV-2 viral variants
    Joob, B.
    Wiwanitkit, V.
    TRANSFUSION CLINIQUE ET BIOLOGIQUE, 2021, 28 (03) : 306 - 306
  • [44] Favipiravir, lopinavir-ritonavir, or combination therapy (FLARE): A randomised, double-blind, 2 x 2 factorial placebo-controlled trial of early antiviral therapy in COVID-19
    Lowe, David M.
    Brown, Li-An K.
    Chowdhury, Kashfia
    Davey, Stephanie
    Yee, Philip
    Ikeji, Felicia
    Ndoutoumou, Amalia
    Shah, Divya
    Lennon, Alexander
    Rai, Abhulya
    Agyeman, Akosua A.
    Checkley, Anna
    Longley, Nicola
    Dehbi, Hakim-Moulay
    Freemantle, Nick
    Breuer, Judith
    Standing, Joseph F.
    PLOS ONE, 2022, 17 (10):
  • [45] Effect of Triple Combination Therapy With Lopinavir-Ritonavir, Azithromycin, and Hydroxychloroquine on QT Interval and Arrhythmic Risk in Hospitalized COVID-19 Patients
    Russo, Vincenzo
    Carbone, Andreina
    Mottola, Filiberto Fausto
    Mocerino, Rosa
    Verde, Raffaele
    Attena, Emilio
    Verde, Nicoletta
    Di Micco, Pierpaolo
    Nunziata, Luigi
    Santelli, Francesco
    Nigro, Gerardo
    Severino, Sergio
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [46] Favipiravir, lopinavir-ritonavir, or combination therapy (FLARE): A randomised, double-blind, 2 x 2 factorial placebo-controlled trial of early antiviral therapy in COVID-19
    Lowe, David M.
    Brown, Li-An K.
    Chowdhury, Kashfia
    Davey, Stephanie
    Yee, Philip
    Ikeji, Felicia
    Ndoutoumou, Amalia
    Shah, Divya
    Lennon, Alexander
    Rai, Abhulya
    Agyeman, Akosua A.
    Checkley, Anna
    Longley, Nicola
    Dehbi, Hakim-Moulay
    Freemantle, Nick
    Breuer, Judith
    Standing, Joseph F.
    PLOS MEDICINE, 2022, 19 (10)
  • [47] Lopinavir pharmacokinetics in COVID-19 patients
    Gregoire, Matthieu
    Le Turnier, Paul
    Gaborit, Benjamin J.
    Veyrac, Gwenaelle
    Lecomte, Raphael
    Boutoille, David
    Canet, Emmanuel
    Imbert, Berthe-Marie
    Bellouard, Ronan
    Raffi, Francois
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2020, 75 (09) : 2702 - 2704
  • [48] Lopinavir-Ritonavir in the Treatment of COVID-19: A Dynamic Systematic Benefit-Risk Assessment
    Vicki Osborne
    Miranda Davies
    Samantha Lane
    Alison Evans
    Jacqueline Denyer
    Sandeep Dhanda
    Debabrata Roy
    Saad Shakir
    Drug Safety, 2020, 43 : 809 - 821
  • [49] Persistence of SARS-CoV-2 in long COVID-19 patients
    Goh, Denise
    Lim, Jeffrey Chun Tatt
    Fernandez, Sonia Bilbao
    Lee, Justina Nadia
    Joseph, Craig Ryan
    Guerrero, Silvia
    Neo, Zhen Wei
    Lau, Mai Chan
    Yeong, Joe Poh Sheng
    JOURNAL OF IMMUNOLOGY, 2022, 208 (01):
  • [50] SARS-CoV-2 Shedding in Dialysis Patients With COVID-19
    Qirjazi, Elena
    Kaunda, Joseph
    Andersen, Tamalee
    Peterson, Joanne
    Iwaasa, Kathryn
    MacRae, Jennifer
    Berenger, Byron M.
    Missaghi, Bayan
    Conly, John M.
    Muruve, Daniel A.
    KIDNEY INTERNATIONAL REPORTS, 2021, 6 (11): : 2897 - 2899
12345